Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal
William Dameshek Prize
The William Dameshek Prize, named for the late William Dameshek, MD, a past president of ASH and the original editor of Blood, recognizes an early- or mid-career individual who has made a recent outstanding contribution to the field of hematology.
The 2017 William Dameshek Prize will be awarded to Benjamin L. Ebert, MD, PhD, of Harvard Medical School, Brigham and Women’s Hospital, and Dana-Farber Cancer Institute in Boston, Massachusetts, for his seminal discoveries in multiple areas of non-malignant and malignant hematology. Dr. Ebert is notable for his leadership in describing the genomic landscape of adult myelodysplastic syndromes (MDS), including identifying critical new roles for ribosomal dysfunction. Specifically, he identified RPS14 as a key gene for deletion 5q MDS. His laboratory discovered the molecular basis of lenalidomide activity in MDS as well as multiple myeloma. Recent studies have characterized clonal hematopoiesis and its contribution to both hematologic malignancies and cardiovascular disease. Along with human genetic studies, Dr. Ebert’s lab has made significant contributions to understanding the biological basis of transformation of hematopoietic cells by somatic mutations. His work has demonstrated creativity, innovative methodology, and direct human relevance.
Henry M. Stratton Medal
The Henry M. Stratton Medal is named after the late Henry Maurice Stratton, co-founder of Grune and Stratton, the medical publishing house that first published ASH’s journal Blood. The prize honors two senior investigators whose contributions to both basic and clinical/ translational hematology research are well recognized and have taken place over a period of several years.
The 2017 Henry M. Stratton Medal for Basic Research will be awarded to Josef Tomas Prchal, MD, of the University of Utah in Salt Lake City, Utah, for his original and lasting scientific contributions to the study of a broad range of red cell disorders. In particular, he is highly regarded for his research on disorders of increased red cell mass, including primary erythrocytosis/polycythemia, as well as inherited and acquired forms of both secondary erythrocytosis and polycythemia vera. Dr. Prchal’s research has contributed substantially to the fundamental understanding of the genetic basis of both primary and secondary polycythemias. His laboratory described the VHL mutation in recessive Chuvash familial polycythemia and elaborated on the pathobiology of EPOR mutations in autosomal dominant familial polycythemia. His genetic investigations of acquired polycythemia vera led to the association of chromosome 9p abnormalities with the disease. More recently, he and his collaborators showed that Tibetans are protected from high altitude polycythemia as a result of a high altitude genetic adaptation, due to variants of the EGLN1 gene and EPAS1 haplotype.
The 2017 Henry M. Stratton Medal for Clinical/Translational Research will be awarded to Sherrill Slichter, MD, of the University of Washington School of Medicine and Bloodworks Northwest in Seattle, Washington, for her major contributions to the field of transfusion medicine over 45 years that have revolutionized platelet transfusion therapy. She has identified methods to significantly prolong the shelf life of platelets, determined approaches to prevent alloimmune platelet refractoriness, identified the minimum number of platelets required to maintain hemostasis, and provided insights into understanding platelet production and viability. These long-term studies have established and improved state-of-the-art practice in transfusion medicine.
Kenneth C. Anderson
Benjamin L. Ebert
Josef T. Prchal
Sherrill J. Slichter
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members